Victoria Niklas
Directeur/Membre du Conseil chez FIBROBIOLOGICS, INC.
Fortune : 87 600 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Peter O'Heeron | M | 61 | 3 ans | |
Josh Distler | M | 48 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Matthew Link | M | 49 | 3 ans | |
Richard C. Cilento | M | 61 | 3 ans | |
Mark McHale | M | 59 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
Stacy Coen | F | 53 | 3 ans | |
Robert Hoffman | M | 58 | 3 ans | |
Mark Andersen | M | 53 | 2 ans | |
Tauhid Ali | M | 56 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
Mark Hannon | M | - |
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | 8 ans |
Marie Yurkovich | M | - |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Edwin Moses | M | 69 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
John Mazziotta | M | - |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 9 ans |
Daniel Curran | M | 57 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
Johnese Spisso | F | 63 |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 8 ans |
David Colpman | M | 62 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
Ramy Farid | M | 59 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 ans |
Hamid Khoja | M | 55 | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
David Feinberg | M | 61 |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | - |
David C. Dreyer | M | 67 |
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | - |
Molly Joel Coye | M | 76 |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 ans |
Virginia Mcferran | F | 60 |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 ans |
Marti Arvin | F | - |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 15 | 65,22% |
Royaume-Uni | 8 | 34,78% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Victoria Niklas
- Réseau Personnel